Inc. (PRTS) Shares: Are They Risky Or Cheap?

74 Inc. (NASDAQ:PRTS) finished Friday with an addition of $0.32 to close at $6.26, an upside of 5.39 percent. An average of 651,760 shares of common stock have been traded in the last five days. There was a gain of $0.25 in the past week, and it reached a new high 3 times over the past 12 months. The last 20 days have seen an average of 1,084,610 shares traded, while the 50-day average volume stands at 1,043,076.

PRTS stock has increased by 15.50% in the last month. The company shares reached their 1-month lowest point of $5.15 on 12/06/22. With the stock rallying to its 52-week high on 01/07/22, shares of the company touched a low of $3.91 and a high of $12.68 in 52 weeks. It has reached a new high 2 times so far this year and lost -44.11% or -$4.94 in price. In spite of this, the price is down -50.63% from the 52-week high.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Insider Transactions

PRTS stock investors should be aware that Inc. (PRTS) stock had its last reported insider trading activity 110 days ago on Dec 14. In this transaction, the insider spent $14,822. VP, General Counsel, Gomez Alfredo, disposed of 10,000 shares at a price of $7.05 on Jun 14. The insider now owns more than $70,500 worth of shares. Prior to that, VP, General Counsel Gomez Alfredo went on to Sale 2,472 shares at $7.23 each on Jun 10. An amount of $17,873 was transacted.

Valuation Metrics Inc. (PRTS) stock’s beta is 2.19. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.54, the price-to-book (PB) ratio at 3.05.

Financial Health

The quick ratio of Inc. for the three months ended September 29 was 0.30, and the current ratio was 1.80, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.19 and a total debt to equity ratio of 0.23 for the quarter ending September 29. Its gross profit as reported stood at $197.28 million compared to revenue of $582.44 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Inc.’s return on assets was 0.10%.

Earnings Surprise

In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$11.16 million in the quarter, while revenues of -$11.16 million were grew 101.79%. The analyst consensus anticipated Inc.’s latest quarter earnings to come in at -$0.06 per share, but it turned out to be -$0.02, a 66.70% surprise. For the quarter, EBITDA amounted to $2.87 million. Shareholders own equity worth $54.56 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Inc. (PRTS) price momentum. RSI 9-day as of the close on 30 December was 58.92%, suggesting the stock is Neutral, with historical volatility in this time frame at 64.06%.

As of today, PRTS’s price is $5.89 +4.16% or $0.25 from its 5-day moving average. PRTS is currently trading +16.57% higher than its 20-day SMA and -25.74% lower than its 100-day SMA. However, the stock’s current price level is +39.11% above the SMA50 and -6.71% below the SMA200.

The stochastic %K and %D were 29.66% and 26.59%, respectively, and the average true range (ATR) was 0.41. With the 14-day stochastic at 53.54% and the average true range at 0.40, the RSI (14) stands at 58.09%. The stock has reached -0.07 on the 9-day MACD Oscillator while the 14-day reading was at -0.15.

Analyst Ratings

Lake Street launched coverage on Inc. (NASDAQ: PRTS) in its analyst report released on March 04, 2022. The firm assigned the stock a Buy rating.


Please enter your comment!
Please enter your name here